“Longevity” doctors reveal what is important for healthy aging

What does longevity medicine want? FOCUS spoke online about this with two specialists: Elisabeth Roider, a dermatologist trained at Harvard Medical School, and Leonie Bode, who completed her specialist training in internal medicine in Switzerland.

Lowering the Bar to Invest in Longevity

Maximon, Marcuard Heritage and GenTwo have announced the launch of a new longevity-related investment opportunity. Their proposal allows professional investors to get access to Maximon’s portfolio of longevity companies via an actively managed certificate (AMC).

Maximon lowers the bar for European longevity investors

Swiss longevity company builder Maximon today unveiled a new investment opportunity designed to allow more professional investors in Europe to invest in longevity ventures. Partnering with wealth management firm Marcuard Heritage and fintech company GenTwo, Maximon is responding to demand from investors to improve access to its Longevity Co-Investment Fund (LCIF).

Marcuard Heritage, GenTwo and Maximon introduce an innovative and new longevity investment opportunity accessible to professional investors

Based on many requests from investors, Marcuard Heritage, one of Switzerland’s leading wealth managers, launched an investment vehicle in the form of an actively managed certificate (AMC) with the support of GenTwo, a Swiss fintech company, to get access to Maximon’s Longevity Co-Investment Fund.

Living 100 years with health: what is the “health span”, the new horizon of longevity

“Longevity could become the biggest industry of the future, since everyone is interested in having a healthy, happy and perhaps even longer life,” says Marc P. Bernegger, founding partner of Maximon, a Swiss company that supports and finances the creation of companies focused on longevity. With four companies in the industry in his portfolio, including Avea and Biolytica, he has just announced that he has raised the investment volume to $33 million.

The five golden rules for aging well

Healthy habits can extend your lifespan. Experts reveal how this can best be achieved. Five tips for healthy aging.

How longevity clinics are becoming suitable for the masses

"Only three years ago, hardly anyone would have come to a longevity center in Zurich," says Marc Bernegger, the founder of the Maximon incubator. Now the topic is emerging from the nerdy corner and becoming mass-market.

German Menopause Startup Frieda Health Raises €2.5M in Pre-Seed Funding

Berlin-based femtech startup Frieda Health has secured EUR 2.5 million in pre-seed funding from the Maximon Longevity Co-Investment Fund, an investor and company builder specializing in the longevity sector. This investment will support Frieda Health’s ongoing development of a digital health platform focused on women’s health, particularly for those aged 45 and above, during menopause.

A Longevity Center for Zurich: Eternal life is now available to buy

The country's first longevity center will be opening in Zurich. Investors around the world are currently pumping huge amounts of money into the latest megatrend, longevity. The prospect of a long, healthy life is based on solid science – at least most of the time.

Storm on longevity products: Avea's sales soar in China

Avea, the provider of innovative premium longevity solutions has generated more than $180’000 in revenues within 24 hours of entering the Chinese market and $250’000 in one week. Thorough planning and tailoring the products to the customer fueled the positive launch.

The Fourth Edition of the Longevity Investors Conference, Held in Gstaad (Switzerland), Unites Visionary Scientists, Industry Titans and Investors for Unprecedented Collaboration

The two full day event, Longevity Investors Conference, held in Gstaad, featured a diverse array of speakers, including leading scientists, venture capitalists, and entrepreneurs, who shared their insights on breakthroughs in longevity. Several high level investors committed millions of dollars to be brought to the industry.

Five simple things you can do to live a healthy, long life, according to this longevity expert

Whether pills, stem cell therapy or cryopreservation: For years, researchers have been looking for ways to extend our lives and keep us forever young. But according to longevity investor Marc Bernegger, you don't have to spend a ton of money or completely change your life to live longer than average. You can find out here which measures the longevity expert integrates into his own everyday life.

Longevity is set to become the dominant industry of our century

The Swiss venture builder Maximon relies on the desire for the fountain of youth in its investments - but it's not just about investments in the beauty segment, but also about preventing age-related diseases.

Unlocking the future of longevity: Highlights from the Longevity Investors Conference 2023

The longevity world went to Switzerland with the aim of uniting science, investment and innovation for a healthier future.

The Business of Pills and Powders that are supposed to slow down Aging

Dietary supplements against aging are experiencing brisk sales. This was heard at the Longevity Investors Conference, which took place for the second time in Gstaad at the end of September 2023. Tobias Reichmuth (44), one of the initiators of the conference at the luxury hotel Le Grand Bellevue, reported on the industry's steep revenue growth in his opening speech.

This is where the super-rich invest in eternal life

The elixir of eternal life: rejuvenation research is booming. The “Longevity” elite met in Gstaad BE this week to discuss the dream of an immortal future.

Updates From Maximon - September

Read our monthly newsletter.

Updates From Maximon - August

Read our monthly newsletter.

Tobias Reichmuths neustes Projekt: Co-Living für Senioren

Tobias Reichmuth bringt ein Co-Living-Konzept für Senioren von den USA nach Europa. In Freiburg und Lugano öffnen wohl 2025 die ersten Standorte.

Investments in anti-aging: In longevity the new big businesses of the billionaires

Longevity and Maximon are featured on Protothema, the biggest Greek news site

Updates From Maximon - July

Read our monthly newsletter.

Avea secured $5M to accelerate its growth

Maximon venture Avea Life has successfully closed a funding round by raising an impressive $5 million. With this significant boost, Avea Life is set to accelerate its growth across Europe and establish its presence in the APAC market.

Updates From Maximon - June

Read our monthly newsletter.

Maximon increases investment volume for Longevity start-ups to CHF 30 million and enlarges its Board of Directors

Maximon - The Company Builder is providing additional capital for the construction of Longevity companies. In addition, the Board of Directors will be further reinforced with Christoph Schwarzenbach.

Updates From Maximon - May

Read our monthly newsletter.

Biolytica secured CHF 5.25 million in funding from Maximon

Maximon fully supports Biolytica on their mission to build out personalised health accessible to everyone. Their innovative approach to healthcare is paving the way for a brighter, more inclusive future.

Updates From Maximon - March & April

Read our monthly newsletter.

Maximon Longevity Prize Applications are Open!

Maximon's Longevity Prize 2023 is now accepting applications for translational longevity research projects! If you have an innovative idea that can help extend the human lifespan, we want to hear from you.

Longevity is near – and what you can do with it | Tobias Reichmuth | TEDxBielBienne

Tobias Reichmuth explores the concept of longevity, discussing how our increasing lifespan presents both challenges and opportunities for society. He offers insights into the latest scientific and technological advancements in anti-aging research and how they could transform the way we live our lives.

Marc P. Bernegger on the emerging field of longevity

Marc P. Bernegger explains how longevity has been transformed from a futurist niche to a scientifically backed Megatrend and how with his latest endeavour, Maximon, he's is capitalizing it.

Updates from Maximon - February

Read our monthly newsletter.

Traum vom langen Leben: Start-ups wollen Schweiz zum Hotspot des Trends machen

Immer mehr Healthtech-Firmen zieht es in die Schweiz. Der gute Zugang zu Kunden und Kapital hilft Firmen, auch in Deutschland zu expandieren.

Forever Young

„Forever Young“: Tech elite and venture capitalists have declared war on death. Thanks to billions invested in promising research results, mankind's greatest dream, eternal life, seems more tangible than ever.

Länger Gesünder Leben

Longer Healthier Life: Read the Transkript article from the authors Georg Kääb and Gwendolyn Dorow about longevity, life extension, rejuvenation and how it is not a field just for esoterics anymore, as more and more investors are getting involved.

Updates from Maximon - January

Read our monthly newsletter for the month of January.

Longevity sector focus at Davos

Longevity remains key focus at World Economic Forum 2023.

Longevity takes over Davos (again)

Longevity stays in the limelight on the streets of Davos for the second time during this year’s World Economic Forum (WEF). The world is growing – and aging – at a rapid rate, and nearly a third of the world’s population will be over 60 years old by 2050.

Updates from Maximon - December

Read our monthly newsletter.

Updates from Maximon - November

Read our monthly newsletter.

Inside the billion-dollar meeting for the mega-rich who want to live forever

Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.

Tobias Reichmuth – the longevity market starts now

Dr Tobias Reichmuth talks taking hardcore science to market without biotech approval risk and the catalyst that is translational research.

Updates from Maximon

Read our monthly newsletter.

Meet the company builders that think they can reverse ageing

Longevity research has often focused on combatting one specific aspect of ageing, like regenerating the liver or the brain. But recently, there’s been a shift towards looking for the silver bullet for all age-related diseases.

‘We want to bring the concept of longevity to life’

Maximon CSO talks clinics, diagnostics, and why longevity is about much more than drug development.

Can we find ways to live beyond 100? Millionaires are betting on it.

At a luxury resort in the Swiss Alps, wealthy investors and scientists are cooking up plans to push the limits of the human lifespan.

Eye-level longevity – why breakthrough research is top investment opportunity

Our pioneers of longevity discuss where the field can be monetised and the breadth of the total addressable market.

Updates from Maximon - August

Read our monthly newsletter for the month of August.

Datenanalysen und langes Leben

Handelszeitung published an interesting story about extending the human lifespan mentioning Maximon, Avea Life, Biolytica and our future longevity ventures.

Elisabeth Roider joins Maximon as a Partner & Chief Scientific and Medical Officer

Driven by the mission to identify and solve the most relevant medical and public health problems, Elisabeth Roider joins Maximon as a Partner & Chief Scientific and Medical Officer.

Updates from Maximon - July

Read our monthly newsletter for the month of July.

Updates from Maximon - June

Read our monthly newsletter for the month of June.

Updates from Maximon - May

Read our monthly newsletter for the month of May.

Longevity takes over Davos – and has Gstaad in its sights

Longevity was one of the most talked about industries on the streets of Davos during this year’s World Economic Forum (WEF), one of the largest gatherings of the world’s financial and political elite.

AVEA included in the “Startups to watch in the DACH Region” list by Sifted

AVEA was included in the “Startups to watch in the DACH Region” list by Sifted.

CHF2.5 million to support the growth of longevity start-up AVEA

Our first longevity venture, Avea Life, announces the closing of a 2.5 million CHF seed financing round.

Updates from Maximon - April

Read our monthly newsletter for the month of April

Ten simple rules for building a successful science start-up

A peer-reviewed publication with a mix of thoughts and experiences from our Founding Partner Dr. Tobias Reichmuth and our Scientific Advisor Prof. Dr. Collin Y. Ewald.

Updates from Maximon - March

Read our monthly newsletter for the month of March.

New innovation longevity research prize launched

The most innovative longevity research could bag 50k CHF thanks to Maximon, which is launching its first Prize for Translational Research in Longevity.

Longevity: Der HealthTech Trend, auf den der Company Builder Maximon setzt

Wer ein neues Schlagwort in der HealthTech-Branche sucht, wird bei Longevity fündig. Kleine wie große Unternehmen suchen verstärkt nach Medikamenten, Therapien und digitalen Mitteln, um die Langlebigkeit von Menschen in überalterten Gesellschaften wie Europa oder Japan zu verbessern.
Mit Maximon, gegründet von den Schweizer Unternehmern Tobias Reichmuth und Marc Bernegger, gibt es einen neuen Company Builder, der auf Longevity-Startups setzt.

European investors have a new obsession: longevity

Imagine a world where the average life expectancy is well over 100 years (and doesn’t involve spending 30 years in a care home). Imagine a world where — thanks to scientific findings made over the last five years — there’s a cure for ageing.

Sophie Chabloz darüber, welche Stoffe das Altern bremsen können

Die Gesundheitswissenschafterin Sophie Chabloz über Nahrungsergänzungsmittel, die verjüngen können. Sie erzählt, was sie selber nimmt und wie es wirkt.

Maximon launches 100 million Longevity Co-Investment Fund

The Longevity Co-Investment Fund finances longevity-focussed start-up companies launched by company-builder Maximon.

First companies benefit from Maximon's Longevity Co-Investment Fund

The newly launched CHF 100 million Fund finances longevity-focussed start-ups founded by Swiss company builder Maximon. The Fund’s first investments include Zug based companies AVEA and Biolytica.

Tobias Reichmuth, Mitgründer Maximon, im Interview

Herr Reichmuth, Longevity, oder Langlebigkeit, tönt ein wenig nach der Suche des heiligen Grals, dem Wunsch, ewig jung zu sein. Wollen Sie das ewige Leben ermöglichen?

The Rising Importance of Crypto in Aging Research

The cryptocurrency world is colliding with aging research and life extension and could change how research gets funded.

Maximon gründet den weltweit ersten Longevity Company Builder

Zug – Maximon ist ein neuer Company Builder mit Sitz in der Schweiz, der das Ziel verfolgt, den “Health-Span”, also die Zeitspanne ohne Altersleiden und Krankheiten, zu verlängern und Menschen eine fitte, gesunde und glückliche Langlebigkeit zu ermöglichen.

Can finance give Old Father Time a run for his money?

It looks like longevity is in it for the long run in Switzerland. Financiers are serious about funding the science of longer and healthier lives. The Swiss “Longevity Valley” dream also has political backing.

Serial Entrepreneurs gründen Company Builder mit Fokus auf Langlebigkei

Maximon soll in den kommenden Jahren systematisch Startups hervorbringen, deren Produkte die Zeitspanne ohne Altersleiden und Krankheiten verlängern. Das vierköpfige Gründungsteam hat bereits Millionen investiert und arbeitet an ersten Projekten.

Maximon builds new longevity companies from scratch

“The real difference is that we really build the companies from scratch,” - Tobias Reichmuth, co-founder of Maximon.